Summary:
Forever 25 Medical Center is conducting a Phase 3 clinical trial that will evaluate the efficacy and safety of an investigational drug in patients with frequent episodic migraines.
Qualified Participants Must:
• Be between 18 and 75 year of age
•
Have no more than 14 migraine headaches per month
Qualified Participants May Receive:
Study medication, study visits, diagnostic tests and compensation up to $1150.